Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0FL1D
|
|||
Former ID |
DNC003990
|
|||
Drug Name |
3-(1-Benzyl-piperidin-3-yl)-2-phenyl-1H-indole
|
|||
Synonyms |
CHEMBL46523; 3-(1-Benzyl-piperidin-3-yl)-2-phenyl-1H-indole; SCHEMBL8524973; BDBM50099274
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C26H26N2
|
|||
Canonical SMILES |
C1CC(CN(C1)CC2=CC=CC=C2)C3=C(NC4=CC=CC=C43)C5=CC=CC=C5
|
|||
InChI |
1S/C26H26N2/c1-3-10-20(11-4-1)18-28-17-9-14-22(19-28)25-23-15-7-8-16-24(23)27-26(25)21-12-5-2-6-13-21/h1-8,10-13,15-16,22,27H,9,14,17-19H2
|
|||
InChIKey |
RXGPCIHYSMKIRI-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Voltage-gated potassium channel Kv11.1 (KCNH2) | Target Info | Inhibitor | [1] |
Pathwhiz Pathway | Muscle/Heart Contraction | |||
Reactome | Voltage gated Potassium channels | |||
WikiPathways | SIDS Susceptibility Pathways | |||
Hematopoietic Stem Cell Differentiation | ||||
Potassium Channels |
References | Top | |||
---|---|---|---|---|
REF 1 | 3-(4-Fluoropiperidin-3-yl)-2-phenylindoles as high affinity, selective, and orally bioavailable h5-HT(2A) receptor antagonists. J Med Chem. 2001 May 10;44(10):1603-14. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.